[BUSINESSWIRE]score: 0.24
Colossal Biosciences adds bluebuck to de-extinction portfolio
May 8, 2026
Colossal Biosciences is applying CRISPR to roan antelope cells using museum-extracted bluebuck DNA to approximate the extinct species' genome. Critics flag the result as a genetic proxy, not a true species revival, raising reproducibility and taxonomic validity concerns for de-extinction science broadly.